Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers

Publisher: John Wiley & Sons Inc

E-ISSN: 1528-1167|56|11|1723-1731

ISSN: 0013-9580

Source: EPILEPSIA, Vol.56, Iss.11, 2015-11, pp. : 1723-1731

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content